CareDx (CDNA) Tops Q4 EPS by 11c, provides guidance

CareDx (NASDAQ: CDNA) reported Q4 EPS of $0.12, $0.11 better than the analyst estimate of $0.01. Revenue for the quarter came in at $108 million versus the consensus estimate of $102.18 million.

GUIDANCE:

CareDx sees FY2026 revenue of $420-444 million, versus the consensus of $417.7 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Medtronic jumps on earnings beat and raised guidance
• Active options: MSFT NIO PLTR HOOD MSTR SOFI MRVL ORCL HTZ PFE